NAD+ For Skin: Evidence, Safety & Provider Guidance

Last reviewed: May 30, 2026

Last updated: May 30, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

NAD+ (nicotinamide adenine dinucleotide) is marketed for skin rejuvenation, but clinical evidence supporting direct skin benefits remains limited compared to established dermatological interventions. Research on NAD+ focuses primarily on cellular energy metabolism and aging pathways, not skin-specific outcomes.

At PlexusDx, we believe informed patients deserve clarity on what evidence actually supports a treatment before investing time and resources. Understanding your metabolic baseline and genetic predispositions can help guide a more personalized conversation with your provider about NAD+ and complementary approaches to skin wellness.

How NAD+ Claims Connect to Cellular Aging Theory

NAD+ is a coenzyme involved in energy production and DNA repair within mitochondria. Proponents suggest declining NAD+ with age contributes to skin aging, and supplementation might restore cellular function. However, direct skin penetration and systemic NAD+ bioavailability remain poorly characterized in human studies.

Most NAD+ research examines metabolic or neurodegenerative conditions, not dermatological outcomes. Few peer-reviewed trials measure actual skin thickness, collagen density, or wrinkle reduction in NAD+ users versus controls, making claims about skin rejuvenation largely theoretical rather than evidence-based.

NAD+ Products and Evidence Quality: A Clinical Framework

NAD+ supplementation takes multiple forms—oral nicotinamide riboside (NR), nicotinamide mononucleotide (NMN), and IV infusions. Each has different bioavailability profiles and cost structures. The table below summarizes what current evidence actually supports for each delivery method regarding skin or aging outcomes.

NAD+ Form	Delivery Route	Skin Evidence	Typical Cost
Nicotinamide Riboside (NR)	Oral supplement	Limited human studies; mostly cellular/mitochondrial research	$30–$60/month
Nicotinamide Mononucleotide (NMN)	Oral supplement	Minimal human data; primarily animal models for aging	$50–$150/month
IV NAD+ Infusion	Intravenous	No rigorous dermatology RCTs; marketed for energy/recovery	$200–$500 per session
Topical NAD+ Products	Skin application	Virtually no peer-reviewed efficacy data for wrinkles or collagen	$30–$100 per product

Proven Skin Interventions and Why They Outrank NAD+ Evidence

Dermatology-backed skin treatments—retinoids, vitamin C serums, sunscreen, professional peels, and laser therapy—have decades of controlled trials demonstrating collagen synthesis, pigmentation improvement, and wrinkle reduction. These interventions directly modulate skin fibroblasts and address photoaging mechanisms with measurable outcomes.

NAD+ supplementation lacks this level of clinical validation for skin. If skin aging is your primary goal, evidence-based dermatological strategies should typically come first. NAD+ may appeal as an adjunctive metabolic support, but it should not replace established prevention and treatment modalities.

Metabolic Biomarkers, Genetics, and NAD+ Response Variability

Individual factors—age, NAD+ pathway gene variants, mitochondrial efficiency, and nutrient absorption capacity—likely influence whether NAD+ supplementation produces any benefit. Genetic variation in sirtuins (NAD+-dependent proteins) and other aging-related pathways may predict responders versus non-responders, though research is still emerging.

Understanding your baseline metabolic health and genetic predispositions in energy and aging pathways can inform whether NAD+ aligns with your broader wellness profile. A qualified provider can contextualize this information within your skin goals, budget, and overall health priorities.

Safety Considerations and Who Should Approach NAD+ Cautiously

NAD+ supplementation is generally well-tolerated in short-term studies, but long-term safety data in humans remains sparse. High-dose nicotinamide has been associated with nausea, skin flushing, and potential liver stress; quality and purity vary significantly across commercial products.

Anyone with liver disease, kidney dysfunction, active cancer, or taking immunosuppressants should discuss NAD+ with their provider before starting. Pregnant and nursing individuals should avoid supplementation. Cost-benefit analysis matters: proven skin interventions with stronger evidence may offer better value for your investment.

How PlexusDx Supports a More Personalized Approach

PlexusDx's Precision Peptide Genetic Test reveals predispositions in metabolic and peptide-related pathways, including genes involved in energy metabolism (mitochondrial function markers) and cellular aging responses. While the test does not directly predict NAD+ supplementation efficacy, understanding your genetic profile in these pathways may help provide context for how your body processes metabolic interventions and ages at a cellular level.

Genetic variants in sirtuins, NAD+ synthesis pathways, and mitochondrial regulatory genes influence how efficiently your cells respond to energy-boosting strategies. The Precision Peptide Genetic Test can reveal predispositions in these areas, supporting a more informed conversation with your provider about whether NAD+ aligns with your metabolic risk profile and wellness goals. However, genetic predisposition does not predict exact supplement response; clinical assessment remains essential.

Combining genetic predisposition data with your personal skin health history, established dermatological evidence, and metabolic baseline empowers you to make decisions alongside your provider with greater confidence. If NAD+ interests you as part of a broader aging or metabolic strategy, this personalized context can help distinguish whether it truly fits your profile or whether proven skin treatments should take priority.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month, or $298 standalone) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $179-$229/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Does NAD+ actually improve skin appearance and reduce wrinkles?

Clinical evidence for NAD+ improving skin is limited. While NAD+ supports cellular energy production theoretically, few human studies measure skin-specific outcomes like collagen density or wrinkle reduction. Established dermatological treatments (retinoids, vitamin C, sunscreen, professional procedures) have far stronger evidence for skin anti-...

What is the difference between oral NAD+ supplements and IV NAD+ infusions for skin?

Oral NAD+ (NR, NMN) has uncertain bioavailability and minimal skin-specific research. IV infusions deliver higher concentrations but lack rigorous dermatology trials. Neither form has proven superiority for skin outcomes compared to topical or systemic dermatological treatments with established efficacy.

How much does NAD+ supplementation cost monthly, and is it worth the investment for skin?

Oral NAD+ supplements range $30–$150/month; IV infusions cost $200–$500 per session. Given weak skin-specific evidence, cost-benefit favors proven dermatological interventions. NAD+ might appeal as adjunctive metabolic support, not primary skin anti-aging therapy.

Are there safety concerns or side effects from taking NAD+ supplements?

Short-term NAD+ is generally well-tolerated, though nausea, flushing, and nausea occur in some users. Long-term human safety data is sparse. High-dose nicotinamide may stress the liver. Those with liver/kidney disease, cancer, or on immunosuppressants should consult a provider before starting.

Can genetic testing help determine if NAD+ supplementation would work for me?

Genetic variants in energy metabolism and aging pathways may influence NAD+ response, but no genetic test currently predicts exact supplement efficacy. PlexusDx's Precision Peptide Genetic Test reveals predispositions in metabolic pathways, which can support a more informed provider conversation about whether NAD+ aligns with your profile.

NAD+ For Skin: Clinical Evidence and Personalized Assessment